Infection Control and Prevention Company Defines Winning US Market Entry Strategy
Discover how an infection prevention company defined a successful US market entry strategy amid regulatory uncertainty for novel wound care disinfectant products.
Home > Education Hub > Case Studies
Case Studies
Small Biotech Company With Complex, Innovative Cell Immunotherapy in Oncology Executes Successful Phase Ib Clinical Trial Across Multiple Sites
Discover how a biotech company executed a complex Phase I trial with Alira Health, ensuring seamless coordination of manufacturing, logistics, and sites.
European Biotech Company Implements a Quality Management System Tailored for Agile SaaS Development
Discover how a biotech SaaS company implemented an ISO 13485 and IEC 62304 compliant QMS tailored to an agile development.
Wound Care Medtech Company Develops Country-Specific Go-To-Market Strategy for Growth
A global medtech company needed support to create a growth strategy blueprint across countries and with the highest impact across the full wound care continuum.
Global Wound Care Medtech Identifies Growth Opportunities via Robust Due Diligence Assessment
A medtech wound care solution provider chose Alira Health for an intensive due diligence assessment to identify inorganic growth opportunities.
Re-establishing Significant Benefit: Biopharma Company Builds a Successful EU Orphan Drug Designation Strategy
Discover the client case study where ODD was granted after strategic EU regulatory support from the Alira Health team strengthened the significant benefit case.